Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28850817 | 0.94 | ALDH1A1 (0.32) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL677197 | 0.94 | ALDH1A1 (0.32) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL7677493 | 0.94 | LMNA (0.39) | LMNAFDPSTP53 | |
| Cyanate SCHEMBL28261530 | 0.91 | ALDH1A1 (0.34) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL28097088 | 0.88 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL5516512 | 0.88 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL27870168 | 0.88 | — | — | |
| SCHEMBL130738 | 0.88 | ALDH1A1 (0.45) | ALDH1A1TDP1TSHRCYP3A4CA2 | |
| SCHEMBL13362092 | 0.87 | CA12 (0.31) | CA2 | |
| SCHEMBL28172341 | 0.86 | NAAA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3953407-B1 | 2-COMPONENT POLYURETHANE COATINGS WITH IMPROVED POT LIFE WITHOUT LOST WEATHERING STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2025-04-30 | — | — | EP | claimed |
| US-20250065609-A1 | MULTILAYER FILM AND USES THEREOF | PROCHIMIR (FR) | 2025-02-27 | — | — | US | claimed |
| CN-114829443-B | Polysiloxane-functionalized polyurethanes for enhancing the hydrophobicity of surfaces | 科思创德国股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| EP-4058499-B1 | POLYSILOXANE FUNCTIONALIZED POLYURETHANES FOR ENHANCING HYDROPHOBISATION OF SURFACES | COVESTRO DEUTSCHLAND AG (DE) | 2024-12-04 | — | — | EP | claimed |
| CN-113614138-B | Two-component polyurethane coating with improved pot life without loss of weatherability | 科思创知识产权两合公司 | 2024-03-29 | — | — | CN | claimed |
| US-20220403094-A1 | POLYSILOXANE-FUNCTIONALIZED POLYURETHANES FOR BOOSTING THE HYDROPHOBICITY OF SURFACES | COVESTRO DEUTSCHLAND AG (DE) | 2022-12-22 | — | — | US | claimed |
| EP-4098678-A1 | PROCESS FOR MODIFYING ISOCYANATES WITH USE OF DIFLUOROSILICATE SALTS AS CATALYST | BASF SE (DE) | 2022-12-07 | — | — | EP | claimed |
| CN-114829443-A | Polysiloxane functionalized polyurethanes for enhancing the hydrophobicity of surfaces | 科思创知识产权两合公司 | 2022-07-29 | — | — | CN | claimed |
| US-20220162371-A1 | TWO-COMPONENT POLYURETHANE COATINGS HAVING IMPROVED POT LIFE WITHOUT A LOSS OF WEATHERING RESISTANCE | COVESTRO DEUTSCHLAND AG (DE) | 2022-05-26 | — | — | US | claimed |
| EP-3024863-B1 | METHOD FOR MANUFACTURING POLYISOCYANATES CONTAINING IMINOOXADIAZINDIONE GROUPS AND THEIR APPLICATION | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-05-04 | — | — | EP | claimed |
| EP-3985044-A1 | PROCESS FOR MODIFYING ISOCYANATES | BASF SE (DE) | 2022-04-20 | — | — | EP | claimed |
| EP-3585826-B1 | METHOD FOR MODIFYING AT LEAST PENTAMETHYLENDIISOCYANATE USING SPIROCYCLIC AMMONIUM SALTS AS CATALYST | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-04-06 | — | — | EP | claimed |
| EP-3024869-B1 | METHOD FOR MANUFACTURING POLYISOCYANATES AND THEIR APPLICATION | COVESTRO DEUTSCHLAND AG (DE) | 2020-05-06 | — | — | EP | claimed |
| US-7199166-B2 | Radiation-curable resins based on hydrogenated ketone-aldehyde and phenol-aldehyde resins and a process for preparing them | DEGUSSA AG (DE) | 2007-04-03 | — | — | US | claimed |
| CN-122037126-A | Polyurethane elastic foaming material, preparation method thereof and supporting pad | 罗莱生活科技股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4731693-A1 | POLYISOCYANATE COMPOSITION | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12605897-B2 | Method for producing an at least partially coated object | STRATASYS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| WO-2002040567-A1 | METHOD FOR CATALYTIC DIMERIZATION OF ISOCYANATES | RHODIA CHIMIE (FR) | 2002-05-23 | — | — | WO | disclosed |
| WO-2001064769-A1 | POWDER PAINT BINDER COMPOSITION | DSM N.V. (NL) | 2001-09-07 | — | — | WO | disclosed |
| EP-1130039-A1 | Powder paint binder composition | DSM N.V. (NL) | 2001-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605897-B2 | Method for producing an at least partially coated object | PUF60, MMS19, RPS15 | ALDH1A1 3533/4885TDP1 2183/4885TSHR 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.